Chemical Compound Review:
Maxalt benzoic acid; N,N-dimethyl-2-[5-(1,2,4...
Synonyms:
RHB-103, SureCN41226, S1607_Selleck, INT-0008, AC-734, ...
- Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group. Visser, W.H., Terwindt, G.M., Reines, S.A., Jiang, K., Lines, C.R., Ferrari, M.D. Arch. Neurol. (1996)
- Pilot study of MK-462 in migraine. Cutler, N.R., Claghorn, J., Sramek, J.J., Block, G., Panebianco, D., Cheng, H., Olah, T.V., Reines, S.A. Cephalalgia : an international journal of headache. (1996)
- Acute treatment of migraine attacks. Ferrari, M.D., Haan, J. Curr. Opin. Neurol. (1995)
- A double-blind, placebo-controlled evaluation of the effect of oral doses of rizatriptan 10 mg on oral contraceptive pharmacokinetics in healthy female volunteers. Shadle, C.R., Liu, G., Goldberg, M.R. Journal of clinical pharmacology. (2000)
- Initial human experience with MK-462 (rizatriptan): a novel 5-HT1D agonist. Sciberras, D.G., Polvino, W.J., Gertz, B.J., Cheng, H., Stepanavage, M., Wittreich, J., Olah, T., Edwards, M., Mant, T. British journal of clinical pharmacology. (1997)
- Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine. McCormack, P.L., Foster, R.H. PharmacoEconomics. (2005)
- The use of stable isotope labeling and liquid chromatography/tandem mass spectrometry techniques to study the pharmacokinetics and bioavailability of the antimigraine drug, MK-0462 (rizatriptan) in dogs. Barrish, A., Olah, T.V., Gatto, G.J., Michel, K.B., Dobrinska, M.R., Gilbert, J.D. Rapid Commun. Mass Spectrom. (1996)
- Pharmacokinetics and food interaction of MK-462 in healthy males. Cheng, H., Polvino, W.J., Sciberras, D., Yogendran, L., Cerchio, K.A., Christie, K., Olah, T.V., McLoughlin, D., James, I., Rogers, J.D. Biopharmaceutics & drug disposition. (1996)
- Comparison of the vasoconstrictor properties of the 5-HT1D-receptor agonists rizatriptan (MK-462) and sumatriptan in human isolated coronary artery: outcome of two independent studies using different experimental protocols. Longmore, J., Hargreaves, R.J., Boulanger, C.M., Brown, M.J., Desta, B., Ferro, A., Schofield, W.N., Taylor, A.A., Hill, R.G. Funct. Neurol. (1997)
- The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers. Van Haarst, A.D., Van Gerven, J.M., Cohen, A.F., De Smet, M., Sterrett, A., Birk, K.L., Fisher, A.L., De Puy, M.E., Goldberg, M.R., Musson, D.G. British journal of clinical pharmacology. (1999)
- A comparison of the contractile effects of 5-hydroxytryptamine, sumatriptan and MK-462 on human coronary artery in vitro. Ferro, A., Longmore, J., Hill, R.G., Brown, M.J. British journal of clinical pharmacology. (1995)
- Pharmacokinetics and tolerability of intravenous rizatriptan in healthy females. Lee, Y., Ermlich, S.J., Sterrett, A.T., Goldberg, M.R., Blum, R.A., Brucker, M.J., McLoughlin, D.A., Olah, T.V., Zhao, J., Rogers, J.D. Biopharmaceutics & drug disposition. (1998)